Concepedia

Thomas A. Brandt

TA

Statistics

Publications

19

Citations

2.2K

H-Index

16

Active since

1993

Affiliations

Pfizer (United States)(Current)

University of Delaware

Scripps Research Institute

Thomas A. Brandt is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

1993–2019

19

Publications

19

Strain-release amination

Ryan Gianatassio, Justin M. Lopchuk, Jie Wang et al. · Science · 2016 · 580 citations

, , +5

The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future

Steven M. Mennen, Carolina Alhambra, C. Liana Allen et al. · Organic Process Research & Development · 2019 · 570 citations · Full text

, , +15

Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity

Justin M. Lopchuk, Kasper Fjelbye, Yu Kawamata et al. · Journal of the American Chemical Society · 2017 · 344 citations · Full text

, , +14

Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors

Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson et al. · Journal of Medicinal Chemistry · 2011 · 134 citations · Full text

, , +17

Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714

David H. Brown Ripin, Dennis E. Bourassa, Thomas A. Brandt et al. · Organic Process Research & Development · 2005 · 77 citations

, , +10

1–5 of 19